A robust gene signature for the prediction of early relapse in stage I–III colon cancer
Colon cancer patients experiencing early relapse consistently exhibited poor survival. The aim of our study was to develop an mRNA signature that can help to detect early relapse cases in stage I–III colon cancer. Public microarray datasets of stage I–III colon cancer samples were extracted from the...
Main Authors: | Weixing Dai, Yaqi Li, Shaobo Mo, Yang Feng, Long Zhang, Ye Xu, Qingguo Li, Guoxiang Cai |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2018-04-01
|
Series: | Molecular Oncology |
Subjects: | |
Online Access: | https://doi.org/10.1002/1878-0261.12175 |
Similar Items
-
A novel gene-pair signature for relapse-free survival prediction in colon cancer
by: Chen P, et al.
Published: (2018-10-01) -
Development and Validation of an Autophagy Score Signature for the Prediction of Post-operative Survival in Colorectal Cancer
by: Zheng Zhou, et al.
Published: (2019-09-01) -
Neutrophil-to-lymphocyte ratio is a prognostic factor for colon cancer: a propensity score analysis
by: Junichi Mazaki, et al.
Published: (2020-09-01) -
Effect of sidedness on survival among patients with early-stage colon cancer: a SEER-based propensity score matching analysis
by: Zhuang-Sheng Huang, et al.
Published: (2021-04-01) -
Molecular Patterns Based on Immunogenomic Signatures Stratify the Prognosis of Colon Cancer
by: Cong Shen, et al.
Published: (2022-02-01)